Author

K. W. Singleton

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Research Focus:cell type annotation· 3 Assay:imaging· 3 Approach:statistical model· 3 Approach:benchmark study· 1 Assay:clinical cohort / trial· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1

Frequent Co-Authors

K. R. Swanson· 4 shared M. M. Mrugala· 4 shared A. B. Porter· 3 shared L. S. Hu· 3 shared S. K. Johnston· 3 shared A. Hawkins-Daarud· 2 shared B. R. Bendok· 2 shared C. R. Rickertsen· 2 shared

Activity by Year

2019-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

K. R. Swanson

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Mapping multiregional imaging-localized biopsies to MRI habitats reveals biologically significant glioma tissue states and associated patterns of cohabitating cellular subpopulations

L. Curtin, K. M. Bond, P. R. Jackson, A. Hawkins-Daarud, S. Velez, N. Shakir, J. C. Urcuyo, G. De Leon, K. W. Singleton, J. M. Langworthy, K. Clark-Swanson, Y. Lassiter-Morris, L. Paulson, C. Sereduk, C. Krishna, , K. R. Swanson

The paper maps MRI-localized glioma biopsies to MRI habitats, identifying transcriptional tissue states and their association with cellular subpopulations and MRI features.

bioRxiv · Mar 23, 2022 · PreprintCancer Biology

Days Gained Response Discriminates Treatment Response in Patients with Recurrent Glioblastoma Receiving Bevacizumab-based Therapies

K. W. Singleton, A. B. Porter, L. S. Hu, S. K. Johnston, K. M. Bond, C. R. Rickertsen, G. De Leon, S. A. Whitmire, K. R. Clark-Swanson, M. M. Mrugala, K. R. Swanson

This study evaluates Days Gained (DG) as a metric for assessing treatment response in recurrent glioblastoma patients receiving bevacizumab-based therapies, showing its prognostic significance for survival outcomes.

bioRxiv · Aug 30, 2019Cancer Biology

Sex differences in seizure at presentation in glioma population

S. Ranjbar, B. J. Anderies, K. W. Singleton, S. K. Johnston, C. R. Rickertsen, A. Sharma, A. B. Porter, M. M. Mrugala, L. S. Hu, J. R. Mitchell, J. B. Rubin, K. R. Swanson

This study examines the association between tumor location and seizure risk in male and female glioma patients.

bioRxiv · Aug 4, 2019 · PreprintCancer Biology

Image-based metric of invasiveness predicts response to adjuvant temozolomide for primary glioblastoma

S. C. Massey, H. White, P. Whitmire, T. Doyle, S. K. Johnston, K. W. Singleton, P. R. Jackson, A. Hawkins-Daarud, B. R. Bendok, A. B. Porter, S. Vora, J. N. Sarkaria, M. M. Mrugala, K. R. Swanson

The paper uses image-based metrics to predict TMZ response in GBM patients, finding that less invasive tumors show greater volumetric response and improved survival.

bioRxiv · Jan 2, 2019Cancer Biology